UNSPSC 51161562: Norethindrone and ethinyl estradiol combination

This classification denotes a mast cell stabilizer with the molecular structure C11H9NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 1M887244YI chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-) but generally known as nivimedone, which bears US NIH Compound Identifier 64753. European Medicines Agency schedules Nivimedone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09333MIG.

The term NIVIMEDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17). SMILES: CC1=C(C=C2C(=C1)C(=O)C(C2=O)[N+](=O)[O-])C.

UNSPSC 51161562 Norethindrone and ethinyl estradiol combination is a Commodity code covering a specific oral contraceptive formulation that state and local governments procure for public health clinics, correctional facilities, and safety-net medical programs. The code names a branded or generic birth-control pill containing the progestin norethindrone and the estrogen ethinyl estradiol in fixed-dose combination, typically used in family planning and reproductive health services delivered by state and county health departments, city clinics, and detention facilities. Purchasing patterns reflect standardized pharmaceutical procurement for high-volume dispensing in publicly funded clinics serving low-income and underinsured populations.

The source does not support identification of recent state and local contract opportunities, issuing jurisdictions, geographic activity, or response dates under this code. No recent solicitations are documented in the available procurement records.